nefazodone has been researched along with carbostyril in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Papakostas, GI; Shelton, RC | 1 |
| Bauman, JN; Cox, LM; Frederick, KS; Kalgutkar, AS; Obach, RS; Sawant, A; Walsky, RL | 1 |
1 review(s) available for nefazodone and carbostyril
| Article | Year |
|---|---|
Augmentation of antidepressants with atypical antipsychotics for treatment-resistant major depressive disorder.
Topics: Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Depressive Disorder, Major; Dibenzothiazepines; Dopamine D2 Receptor Antagonists; Drug Resistance; Drug Therapy, Combination; Fluoxetine; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Serotonin 5-HT2 Receptor Antagonists; Thiazoles; Trazodone; Triazoles | 2008 |
1 other study(ies) available for nefazodone and carbostyril
| Article | Year |
|---|---|
Comparison of the bioactivation potential of the antidepressant and hepatotoxin nefazodone with aripiprazole, a structural analog and marketed drug.
Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Aripiprazole; Cyanides; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Glutathione; Humans; Microsomes, Liver; Piperazines; Quinolones; Triazoles | 2008 |